BRPI0410455A - sistema de liberação de drogas, métodos de contracepção, de prover concomitantemente contracepção e tratamento ou prevenção de uma doença sexualmente transmitida, uso do sistema de liberação de drogas, e, método de fabricar o sistema de liberação de drogas em três camadas - Google Patents

sistema de liberação de drogas, métodos de contracepção, de prover concomitantemente contracepção e tratamento ou prevenção de uma doença sexualmente transmitida, uso do sistema de liberação de drogas, e, método de fabricar o sistema de liberação de drogas em três camadas

Info

Publication number
BRPI0410455A
BRPI0410455A BRPI0410455-2A BRPI0410455A BRPI0410455A BR PI0410455 A BRPI0410455 A BR PI0410455A BR PI0410455 A BRPI0410455 A BR PI0410455A BR PI0410455 A BRPI0410455 A BR PI0410455A
Authority
BR
Brazil
Prior art keywords
drug release
release system
drug
prevention
treatment
Prior art date
Application number
BRPI0410455-2A
Other languages
English (en)
Inventor
Rudolf Johannes Jo Groenewegem
Wouter De Graaff
Henk Jan Out
Original Assignee
Akzo Nobel Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=36701594&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BRPI0410455(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Akzo Nobel Nv filed Critical Akzo Nobel Nv
Publication of BRPI0410455A publication Critical patent/BRPI0410455A/pt
Publication of BRPI0410455B1 publication Critical patent/BRPI0410455B1/pt
Publication of BRPI0410455B8 publication Critical patent/BRPI0410455B8/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A61K9/0036—Devices retained in the vagina or cervix for a prolonged period, e.g. intravaginal rings, medicated tampons, medicated diaphragms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0092—Hollow drug-filled fibres, tubes of the core-shell type, coated fibres, coated rods, microtubules or nanotubes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/34—Gestagens

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Reproductive Health (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Endocrinology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Diabetes (AREA)
  • Nanotechnology (AREA)
  • Biotechnology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)

Abstract

"SISTEMA DE LIBERAçãO DE DROGAS, MéTODOS DE CONTRACEPçãO, DE PROVER CONCOMITANTEMENTE CONTRACEPçãO E TRATAMENTO OU PREVENçãO DE UMA DOENçA SEXUALMENTE TRANSMITIDA, USO DO SISTEMA DE LIBERAçãO DE DROGAS, E, MéTODO DE FABRICAR O SISTEMA DE LIBERAçãO DE DROGAS EM TRêS CAMADAS". A presente invenção provê um sistema de liberação de drogas compreendendo, pelo menos, um compartimento consistindo de (í) um núcleo de polímero termoplástico carregado com drogas, (ii) uma camada intermediária de polímero termoplástico carregada com drogas, e (iii) uma película de polímero termoplástico não medicamentosa, cobrindo a camada intermediária, em que referida camada intermediária é carregada com (a) cristais de um primeiro composto farmaceuticamente ativo e com (b) um segundo composto farmaceuticamente ativo em forma dissolvida e em que o referido núcleo é carregado com referido segundo composto em forma dissolvida.
BRPI0410455A 2003-05-23 2004-05-19 sistema de liberação de drogas, uso do sistema de liberação de drogas, e, método de fabricar o sistema de liberação de drogas em três camadas BRPI0410455B8 (pt)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US47305503P 2003-05-23 2003-05-23
EP03101490 2003-05-23
EP03101490.5 2003-05-23
US60/473,055 2003-05-23
PCT/EP2004/050850 WO2004103336A2 (en) 2003-05-23 2004-05-19 Drug delivery system

Publications (3)

Publication Number Publication Date
BRPI0410455A true BRPI0410455A (pt) 2006-06-13
BRPI0410455B1 BRPI0410455B1 (pt) 2018-05-15
BRPI0410455B8 BRPI0410455B8 (pt) 2021-05-25

Family

ID=36701594

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0410455A BRPI0410455B8 (pt) 2003-05-23 2004-05-19 sistema de liberação de drogas, uso do sistema de liberação de drogas, e, método de fabricar o sistema de liberação de drogas em três camadas

Country Status (29)

Country Link
US (3) US8333983B2 (pt)
EP (1) EP1631255B1 (pt)
JP (1) JP4685780B2 (pt)
KR (1) KR101116267B1 (pt)
CN (1) CN1794974B (pt)
AR (1) AR044547A1 (pt)
AU (1) AU2004241747B2 (pt)
BR (1) BRPI0410455B8 (pt)
CA (1) CA2524665C (pt)
CO (1) CO5630021A2 (pt)
CY (1) CY1113500T1 (pt)
DK (1) DK1631255T3 (pt)
EC (1) ECSP056250A (pt)
ES (1) ES2396100T3 (pt)
HR (1) HRP20050945B1 (pt)
IL (1) IL171622A (pt)
IS (1) IS2864B (pt)
MX (1) MXPA05012595A (pt)
NO (1) NO336456B1 (pt)
NZ (1) NZ543652A (pt)
PE (1) PE20050815A1 (pt)
PL (1) PL1631255T3 (pt)
PT (1) PT1631255E (pt)
RU (1) RU2340344C2 (pt)
SI (1) SI1631255T1 (pt)
TW (1) TWI336627B (pt)
UA (1) UA84287C2 (pt)
WO (1) WO2004103336A2 (pt)
ZA (1) ZA200509450B (pt)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8110211B2 (en) * 2004-09-22 2012-02-07 Advanced Cardiovascular Systems, Inc. Medicated coatings for implantable medical devices including polyacrylates
US8703167B2 (en) * 2006-06-05 2014-04-22 Advanced Cardiovascular Systems, Inc. Coatings for implantable medical devices for controlled release of a hydrophilic drug and a hydrophobic drug
ES2425842T3 (es) * 2006-11-20 2013-10-17 Intervet International B.V. Sistema de administración de fármaco con forma helicoidal
CA2669833A1 (en) * 2006-11-22 2008-05-29 N.V. Organon Vaginal delivery system for mirtazapine
US8741329B2 (en) * 2007-09-21 2014-06-03 Merck Sharp & Dohme B.V. Drug delivery system
EP2062568A1 (en) * 2007-11-22 2009-05-27 Bayer Schering Pharma Oy Vaginal delivery system
WO2009141309A1 (en) * 2008-05-20 2009-11-26 N.V. Organon Delivery system for paliperidone
ES2344673B1 (es) * 2008-08-07 2011-05-03 Italfarmaco, S.A. Uso de estriol en la preparacion de una formulacion farmaceutica parael tratamiento de atrofia vaginal en mujeres con riesgo de potologiatumoral.
FI121000B (fi) * 2008-11-19 2010-06-15 Bayer Schering Pharma Oy Intravaginaalinen antojärjestelmä ja menetelmä sen valmistamiseksi
WO2010077096A2 (ko) * 2008-12-31 2010-07-08 한올바이오파마주식회사 약물전달기구
MX2011009679A (es) * 2009-03-17 2011-09-30 Intervet Int Bv Dispositivo de suministro de farmaco zootecnico.
IN2012DN00711A (pt) * 2009-07-21 2015-06-19 Population Council Inc
CN103025320A (zh) * 2010-03-28 2013-04-03 伊万斯彻有限公司 阴道内药物递送装置
US8580294B2 (en) 2010-10-19 2013-11-12 International Partnership For Microbicides Platinum-catalyzed intravaginal rings
EP2734262B1 (en) * 2011-07-20 2018-02-28 Patrick F. Kiser Intravaginal rings for drug delivery
ES2885523T3 (es) 2011-11-23 2021-12-14 Therapeuticsmd Inc Formulaciones y terapias de reposición hormonal de combinación naturales
US9301920B2 (en) 2012-06-18 2016-04-05 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US20130338122A1 (en) 2012-06-18 2013-12-19 Therapeuticsmd, Inc. Transdermal hormone replacement therapies
US10806740B2 (en) 2012-06-18 2020-10-20 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US20150196640A1 (en) 2012-06-18 2015-07-16 Therapeuticsmd, Inc. Progesterone formulations having a desirable pk profile
US10806697B2 (en) 2012-12-21 2020-10-20 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10537581B2 (en) 2012-12-21 2020-01-21 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US11266661B2 (en) 2012-12-21 2022-03-08 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US9180091B2 (en) 2012-12-21 2015-11-10 Therapeuticsmd, Inc. Soluble estradiol capsule for vaginal insertion
US10568891B2 (en) 2012-12-21 2020-02-25 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US11246875B2 (en) 2012-12-21 2022-02-15 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10471072B2 (en) 2012-12-21 2019-11-12 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10137031B2 (en) 2013-11-14 2018-11-27 International Partnership For Microbicides, Inc. Combination therapy intravaginal rings
US10413504B2 (en) * 2013-12-11 2019-09-17 Merck Sharp & Dohme Corp. Intravaginal ring drug delivery system
EP3079659B1 (en) 2013-12-11 2020-10-28 Merck Sharp & Dohme B.V. Drug delivery system for delivery of anti-virals
MX2016014281A (es) 2014-05-22 2017-02-22 Therapeuticsmd Inc Formulaciones y terapias de reemplazo de combinación de hormonas naturales.
US10328087B2 (en) 2015-07-23 2019-06-25 Therapeuticsmd, Inc. Formulations for solubilizing hormones
AU2017239645A1 (en) 2016-04-01 2018-10-18 Therapeuticsmd, Inc. Steroid hormone pharmaceutical composition
US10286077B2 (en) 2016-04-01 2019-05-14 Therapeuticsmd, Inc. Steroid hormone compositions in medium chain oils
AU2017263253B2 (en) * 2016-05-12 2022-04-14 Merck Sharp & Dohme Llc Drug delivery system for the delivery of antiviral agents
US10406336B2 (en) 2016-08-03 2019-09-10 Neil S. Davey Adjustable rate drug delivery implantable device
BR112020008231A2 (pt) 2017-10-27 2020-10-27 Renovia, Inc. dispositivos, sistemas e métodos para treinamento dos músculos do assoalho pélvico
KR20210013088A (ko) 2018-05-24 2021-02-03 셀라니즈 이브이에이 퍼포먼스 폴리머스 엘엘씨 거대 분자 약물 화합물의 지속적인 방출을 위한 이식가능 장치
KR20210013089A (ko) 2018-05-24 2021-02-03 셀라니즈 이브이에이 퍼포먼스 폴리머스 엘엘씨 거대 분자 약물 화합물의 지속적인 방출을 위한 이식가능 장치
EP3803866A4 (en) 2018-05-24 2022-03-16 Nureva Inc. METHOD, APPARATUS, AND COMPUTER READABLE MATERIALS FOR MANAGING SEMI-CONSTANT (PERSISTENT) SOUND SOURCES IN MICROPHONE CATCH/HOME AREAS
CA3122847A1 (en) * 2018-12-11 2020-06-18 Lupin Inc. Drug delivery system for ultra-low dose estrogen combinations and methods and uses thereof
KR102159904B1 (ko) 2020-04-24 2020-09-24 강경원 약물 방출 고리를 구비한 월경컵
BR112023022439A2 (pt) 2021-04-26 2023-12-26 Celanese Eva Performance Polymers Llc Dispositivo implantável para liberação sustentada de um composto de fármaco macromolecular
EP4215181A1 (en) * 2022-01-21 2023-07-26 Sever Pharma Solutions An intravaginal ring
WO2023200974A1 (en) * 2022-04-14 2023-10-19 Yale University Nanoparticles and nanoparticle-releasing vaginal rings
WO2024030116A1 (en) * 2022-08-01 2024-02-08 Lupin Inc. Drug delivery system for ultra-low dose estrogen combinations and methods and uses thereof
EP4487840A1 (en) 2023-07-07 2025-01-08 Sever Pharma Solutions A three-layered intravaginal ring

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3545439A (en) * 1968-01-04 1970-12-08 Upjohn Co Medicated devices and methods
US3854480A (en) * 1969-04-01 1974-12-17 Alza Corp Drug-delivery system
US3995633A (en) 1975-12-02 1976-12-07 The Procter & Gamble Company Vaginal Medicament dispensing device
US3995634A (en) 1975-12-02 1976-12-07 The Procter & Gamble Company Vaginal cavity dispensing means and method
US4237885A (en) 1978-10-23 1980-12-09 Alza Corporation Delivery system with mated members for storing and releasing a plurality of beneficial agents
US4292965A (en) * 1978-12-29 1981-10-06 The Population Council, Inc. Intravaginal ring
DE3040978A1 (de) 1980-10-28 1982-05-27 Schering Ag, 1000 Berlin Und 4619 Bergkamen Vaginalring
US4629449A (en) * 1982-07-29 1986-12-16 Alza Corporation Vaginal dispenser for dispensing beneficial hormone
DE3571924D1 (en) 1984-04-11 1989-09-07 Thiemann Arzneimittel Gmbh Dosage units for controlled release of active material
US4596576A (en) 1984-10-12 1986-06-24 Akzo N.V. Release system for two or more active substances
DE19975054I2 (de) * 1987-08-08 2000-04-13 Akzo Nobel Nv Kontrazeptives Implantat
US5766632A (en) * 1993-10-01 1998-06-16 Legere Pharmaceuticals, Ltd. Method of using lectins for contraception
JP3720386B2 (ja) * 1993-12-27 2005-11-24 住友製薬株式会社 薬物放出制御製剤
WO1997002015A1 (en) * 1995-07-04 1997-01-23 Akzo Nobel N.V. Ring-shaped devices
US5972372A (en) 1996-07-31 1999-10-26 The Population Council, Inc. Intravaginal rings with insertable drug-containing core
IL123813A0 (en) * 1997-04-11 1998-10-30 Akzo Nobel Nv Drug delivery system for two or more active substances
JP2002508284A (ja) 1997-12-12 2002-03-19 アクゾ・ノベル・エヌ・ベー 膣内挿入リング用包装材料
US6579533B1 (en) * 1999-11-30 2003-06-17 Bioasborbable Concepts, Ltd. Bioabsorbable drug delivery system for local treatment and prevention of infections
CN1536986B (zh) * 2001-03-27 2012-07-04 沃纳奇尔科特(爱尔兰)有限公司 用于抗微生物剂给药的阴道内药物递送装置
WO2003000156A1 (en) * 2001-06-22 2003-01-03 Southern Biosystems, Inc. Zero-order prolonged release coaxial implants
PL367961A1 (en) * 2001-08-31 2005-03-07 Schering Oy Drug delivery system

Also Published As

Publication number Publication date
KR20060015617A (ko) 2006-02-17
HK1084337A1 (en) 2006-07-28
IS2864B (is) 2014-01-15
AR044547A1 (es) 2005-09-21
UA84287C2 (uk) 2008-10-10
HRP20050945A2 (en) 2006-02-28
TWI336627B (en) 2011-02-01
IL171622A (en) 2012-01-31
HRP20050945B1 (hr) 2014-03-14
CN1794974A (zh) 2006-06-28
WO2004103336A2 (en) 2004-12-02
MXPA05012595A (es) 2006-02-22
CA2524665A1 (en) 2004-12-02
BRPI0410455B1 (pt) 2018-05-15
RU2340344C2 (ru) 2008-12-10
US8858977B2 (en) 2014-10-14
PE20050815A1 (es) 2005-10-04
US8900615B2 (en) 2014-12-02
TW200505519A (en) 2005-02-16
US20130115265A1 (en) 2013-05-09
NO336456B1 (no) 2015-08-31
CY1113500T1 (el) 2016-06-22
DK1631255T3 (da) 2013-02-04
ES2396100T3 (es) 2013-02-19
RU2005140277A (ru) 2006-06-10
US20130078286A1 (en) 2013-03-28
CA2524665C (en) 2011-12-20
ECSP056250A (es) 2006-04-19
KR101116267B1 (ko) 2012-03-14
PT1631255E (pt) 2013-01-07
NO20055171D0 (no) 2005-11-03
CO5630021A2 (es) 2006-04-28
AU2004241747A1 (en) 2004-12-02
EP1631255B1 (en) 2012-10-17
WO2004103336A3 (en) 2005-01-06
NZ543652A (en) 2009-06-26
BRPI0410455B8 (pt) 2021-05-25
PL1631255T3 (pl) 2013-03-29
JP4685780B2 (ja) 2011-05-18
US8333983B2 (en) 2012-12-18
US20060280771A1 (en) 2006-12-14
SI1631255T1 (sl) 2013-02-28
ZA200509450B (en) 2007-03-28
JP2007502316A (ja) 2007-02-08
CN1794974B (zh) 2010-09-29
IS8086A (is) 2005-10-24
AU2004241747B2 (en) 2010-03-11
EP1631255A2 (en) 2006-03-08
NO20055171L (no) 2006-01-31

Similar Documents

Publication Publication Date Title
BRPI0410455A (pt) sistema de liberação de drogas, métodos de contracepção, de prover concomitantemente contracepção e tratamento ou prevenção de uma doença sexualmente transmitida, uso do sistema de liberação de drogas, e, método de fabricar o sistema de liberação de drogas em três camadas
BRPI0816887A8 (pt) Sistema de administração de droga, métodos de contracepção, para prover concomitantemente contracepção e tratar ou evitar uma doença sexualmente transmitida, e para fabricar o sistema de administração de droga em três-camadas, e, uso do sistema de administração de droga
BRPI0411986A (pt) forma de dosagem farmacêutica multiparticulada, contendo substáncias peptìdicas ou protéicas ativas formuladas de maneira mucoadesiva, e um método para produzir a dita forma de dosagem farmacêutica
JP2007502316A5 (pt)
BR9808888A (pt) Formas de dosagem e método de melhorar disfunção erétil masculina
BRPI0408105A (pt) sistema de distribuição para droga e terapia celular
WO2006058249A3 (en) Methods and compositions for deterring abuse of orally administered pharmaceutical products
JP2011504484A (ja) 膣内薬剤放出システム
JP2005531570A (ja) 貫粘膜薬物送達及び凍結保護のための組成物及び方法
AR044077A1 (es) Peliculas consumibles por via oral que se disuelven rapidamente, que contienen un edulcorante
EP1539069A4 (en) TRANSMUCOSAL DELIVERY OF CANNABINOIDS
EP1796629A4 (en) SEMICONDUCTORY DISPENSER AND PHARMACEUTICAL COMPOSITIONS
AR073801A1 (es) Emulsiones de liberacion modificadas para aplicacion en la piel o mucosa vaginal
ECSP077182A (es) Metodos para el tratamiento de infecciones endobronquiales
CA2559224A1 (en) Drug delivery system based on polyethylene vinylacetate copolymers
WO2006031856A3 (en) Biosynchronous transdermal drug delivery
EP0862396A4 (en) INTRAVAGINAL RINGS WITH READY-TO-USE MEDICINE-BASED CORE
WO2007149864A3 (en) Non-hormonal vaginal contraceptive
WO2007106550A3 (en) Methods and compositions for deterring abuse of orally administered pharmaceutical products
WO2005013906A3 (en) pH-RESPONSIVE FILM FOR INTRAVAGINAL DELIVERY OF A BENEFICIAL AGENT
BRPI0515815A (pt) forma medicamentosa de multipartìculas contendo substáncias ativas de ácido nucléico formuladas mucoadesivas bem como processo para preparação da forma medicamentosa
ATE206043T1 (de) Örtliche arzneistoffabgabe in tieferen magendarmtraktabschnitten
Kumar et al. Intra vaginal drug delivery system (novel drug delivery system)
BR0008057A (pt) Forma cristalina de eplerenona apresentando velocidade de dissolução intensificada
AU777508B2 (en) Methods and kits for treating vulvovaginal candidiasis with miconazole nitrate

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B25A Requested transfer of rights approved

Owner name: MSD OSS B.V. (NL)

B25A Requested transfer of rights approved

Owner name: ORGANON BIOSCIENCES NEDERLAND B.V. (NL)

B25A Requested transfer of rights approved

Owner name: MERCK SHARP AND DOHME B.V. (NL)

B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]
B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 19/05/2004 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF

B21F Lapse acc. art. 78, item iv - on non-payment of the annual fees in time

Free format text: REFERENTE A 21A ANUIDADE.

B21H Decision of lapse of a patent or of a certificate of addition of invention cancelled [chapter 21.8 patent gazette]

Free format text: ANULADA A PUBLICACAO CODIGO 21.6 NA RPI NO 2828 DE 18/03/2025 POR TER SIDO INDEVIDA.